• No results found

Explorations of combinational therapy in cancer : targeting the tumor and its microenvironment by combining chemotherapy with chemopreventive approaches

N/A
N/A
Protected

Academic year: 2021

Share "Explorations of combinational therapy in cancer : targeting the tumor and its microenvironment by combining chemotherapy with chemopreventive approaches"

Copied!
5
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

Explorations of combinational therapy in cancer : targeting the tumor and its microenvironment by combining chemotherapy with chemopreventive approaches

Wijngaarden, J.W. van

Citation

Wijngaarden, J. W. van. (2011, June 29). Explorations of combinational therapy in cancer : targeting the tumor and its

microenvironment by combining chemotherapy with chemopreventive approaches. Retrieved from https://hdl.handle.net/1887/17745

Version: Corrected Publisher’s Version

License: Licence agreement concerning inclusion of doctoral thesis in the Institutional Repository of the University of Leiden Downloaded

from: https://hdl.handle.net/1887/17745

Note: To cite this publication please use the final published version (if applicable).

(2)

Explorations of

combinational thErapy in cancEr

Targeting the tumor and its microenvironment

by combining chemotherapy with chemopreventive approaches

(3)

Explorations of

combinational thErapy in cancEr

Targeting the tumor and its microenvironment

by combining chemotherapy with chemopreventive approaches

Proefschrift ter verkrijging van

de graad van Doctor aan de Universiteit leiden, op gezag van rector magnicus prof.mr. p.f. van der heijden,

volgens besluit van het college voor promoties te verdedigen op woensdag 29 juni 2011

klokke 13.45 uur

door

Johannes Willem van Wijngaarden geboren te purmerend

in 1977

(4)

promotiecommissie

promotor prof. dr. c.W.G.m. lwik co-promotor Dr. E.r. van beek overige leden prof. dr. s.E. papapoulos

prof. dr. V.W.m. van hinsbergh (VU amsterdam) prof. dr. p.h. reitsma

the studies presented in this thesis were performed at the department of Endocrinology and metabolic Diseases at the leiden University medical center, leiden, the netherlands.

the research described in this thesis was supported by grants from the the netherlands organisation for scientic research (pGn 902-17-090) and the Dutch cancer society (rUl2000-2196).

lay-out and cover-design: Josine Krom, josineck@yahoo.com printed by: Whrmann print service.

the printing of this thesis was nancially supported by the 'Jurriaanse stichting' which is greatfully acknowledged.

Contents Chapter

1. General introduction 1. tumorigenesis 2. tumor progression

2.1 role of the tumor microenvironment 2.2 tumor angiogenesis

2.3 tumor metastasis

2.4 the principles of Darwinian evolution in cancer 3. tumor therapy

3.1 conventional tumor therapy: chemo monotherapy and drug resistance 3.2 conventional tumor therapy:

combination chemotherapy and multi-drug resistance 3.3 chemopreventive tumor therapy; anti-angiogenesis therapy 3.4 Vascular targeting

3.5 Exploring the tumor microenvironment as anti-cancer target 4. outline of this thesis

2. Identication of differentially expressed genes in a renal cell carinoma tumor model after endostatin-treatment

3. An in vitro model that can distinguish between effects on angiogenesis and on established vasculature: actions of TNP-470, marimastat and the tubulin-binding agent Ang-510

4. Celecoxib enhances doxorubicin-induced cytotoxicity in MDA-MB231 cells by NF-kappaB-mediated increase of intracellular doxorubicin accumulation

pages

9 11 13 13 15 17 19 20 20 21

22 25 25 28 39

65

81

(5)

5. Synergistic effect of bisphosphonate and docetaxel on the growth of bone metastasis in an animal model of established metastatic bone disease

6. General discussion

1. Differential gene expression in a renal cell carcinoma model after treatment with endostatin

2. a new model to identify and discriminate between new potential anti-angionic drugs and vascular disruptive agents

3. combination therapies in overcoming treatment resistance:

enhancing doxorubicin- cytotoxicity by nf-κb-mediated increase of doxorubicin accumulation

4. combination therapies in overcoming treatment resistance:

targeting tumor stroma of bone metastases with bone resorption inhibitors

5. conclusions and future perspectives

7. Summary

Samenvatting List of abbreviations Acknowledgements Curriculum vitae List of publications

103

119 121 124 126

128

130

145 149 152 157 159 161

Referenties

GERELATEERDE DOCUMENTEN

the preferential targeting of the already established tumor vascular network and makes use of so-called vascular-disruptive agents (VDas) 121-123. all VDas

in order to determine whether loss of cbfa1/osf2- positive granulocytes was restricted to endostatin treatment in the rc-9 tumor model, we stained histological sections

an in vitro model that can distinguish between effects on angiogenesis and on established vasculature: actions of tnp-470, marimastat and the tubulin-binding agent ang-510..

in the present study, we show that the specic cox-2 inhibitor celecoxib enhances the inhibitory effect of doxorubicin (dox) on human mDa-mb231 breast tumor growth in

We show here that combined treatment with a potent bisphosphonate and a cytostatic, at doses that have minimal effect on tumor growth when given alone, protects skeletal integrity

these ndings show further the role the microenvironment can play in tumor progression and emphasizes the therapeutic potential of chemopreventive agents, as they may have a role

De fases die van belang zijn voor een tumor om zich verder te ontwikkelen worden steeds duidelijker in kaart gebracht, waarbij het duidelijk wordt dat niet alleen de tumor zelf,

Explorations of combinational therapy in cancer : targeting the tumor and its microenvironment by combining chemotherapy with chemopreventive approaches.. Retrieved